Plantimex Recalls Mamisan Lidocaine Ointment Containers Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging

Thu Dec 18 2025

View source

- views

Recall Summary

This recall involves Mamisan Pain Relieving Topical Ointment jars. The ointment comes in an orange container with a white continuous thread lid and has the Mamisan trademark printed on top of the lid and on the label. The ointment was sold in a 3.52 ounce plastic jar. The wraparound label includes instructions and drug facts. Only jars with UPC code 860006498115 are included in the recall.

Affected Products

Product Name	Number of Affected Units
Mamisan Pain Relieving Topical Ointment	About 50,330

Remedies

Remedy
Consumers should immediately secure the recalled ointment jars out of the sight and reach of children and contact Plantimex to receive a free replacement lid. Once the product is secured with the replacement lid, consumers can use the product, as directed.

Hazards

Hazard	Type of Hazard
The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.	Not specified

Injuries

Injury
None reported

Manufacturers

Manufacturer
MiramarLab, of Doral, Florida

Retailers

Retailer
Walmart and Target stores nationwide and online at Target.com from April 2024 through October 2025 for about $10.

0 views